(Q39382635)

11 September 2017

Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population (English)

1 reference

11 September 2017

1 reference

17

Frank B Hu

1 reference

11 September 2017

Xinwen Min

13

0 references

author name string

Xiayun Dai

1

1 reference

11 September 2017

Jing Yuan

2

1 reference

11 September 2017

Ping Yao

3

1 reference

11 September 2017

Binyao Yang

4

1 reference

11 September 2017

Lixuan Gui

5

1 reference

11 September 2017

Xiaomin Zhang

6

1 reference

11 September 2017

Huan Guo

7

1 reference

11 September 2017

Youjie Wang

8

1 reference

11 September 2017

Weihong Chen

9

1 reference

11 September 2017

Sheng Wei

10

1 reference

11 September 2017

Xiaoping Miao

11

1 reference

11 September 2017

Xiulou Li

12

1 reference

11 September 2017

Handong Yang

14

1 reference

11 September 2017

Weimin Fang

15

1 reference

11 September 2017

Yuan Liang

16

1 reference

11 September 2017

Tangchun Wu

18

1 reference

11 September 2017

Meian He

19

1 reference

11 September 2017

18 July 2013

1 reference

European Journal of Epidemiology

11 September 2017

1 reference

11 September 2017

28

1 reference

11 September 2017

8

1 reference

11 September 2017

669-676

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-013-9829-4

11 September 2017

0 references

cites work

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Prevalence of the metabolic syndrome and overweight among adults in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Uric acid and the development of metabolic syndrome in women and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Uric acid: a surrogate of insulin resistance in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

A causal role for uric acid in fructose-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Genome-wide association study of hematological and biochemical traits in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Genetic predisposition to obesity leads to increased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Mendelian randomization: prospects, potentials, and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Mendelian randomization as an instrumental variable approach to causal inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9829-4

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

12 December 2020

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

12 December 2020

Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?

1 reference

12 December 2020

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents

1 reference

12 December 2020

Sex differences in uric acid and risk factors for coronary artery disease

1 reference

12 December 2020

Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group

1 reference

12 December 2020

10.1007/S10654-013-9829-4

Identifiers

DOI

1 reference

11 September 2017

1 reference